Influence of hemofiltration on plasma cytokine levels and platelet activation during extra corporeal membrane oxygenation

Scandinavian Cardiovascular Journal

Volumn 34, Issue 3, 2000, Pages 315-320

  Skogby, Maria ^a,b   Adrian, Katrin ^a   Friberg, Lars Göran ^a   Mellgren, Gösta ^a   Mellgren, Karin ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ECLS; Extracorporeal circulation; Hemofiltration; Interleukins; Platelet membrane receptors; Platelets

Indexed keywords

BETA THROMBOGLOBULIN; CYTOKINE; FIBRINOGEN RECEPTOR;

ARTICLE; BLOOD; COMPARATIVE STUDY; EXTRACORPOREAL OXYGENATION; HEMOFILTRATION; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LEUKOCYTE COUNT; METABOLISM; NEUTROPHIL; PHYSIOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

BETA-THROMBOGLOBULIN; CYTOKINES; EXTRACORPOREAL MEMBRANE OXYGENATION; HEMOFILTRATION; HEMOGLOBINOMETRY; HUMANS; LEUKOCYTE COUNT; NEUTROPHILS; PLATELET ACTIVATION; PLATELET COUNT; PLATELET MEMBRANE GLYCOPROTEINS;

EID: 0034207758     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/713783129     Document Type: Article

References (22)

1. Zobel G, Stein J, Kuttning M, Beitske A, Metzler H, Rigler B. Continuous extracorporeal fluid removal in children with low cardiac output after cardiac operations. J Thorac Cardiovasc Surg 1991; 101: 593-597.
2. Nagashima M, Shinòka T, Nollert G, Shum-Tim D, Rader C, Mayer J. High-volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonatal lambs after deep hypothermic circulatory arrest. Circulation 1998; 98: II378-II384.
3. Andreasson S, Göthberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993; 56: 1515-1517.
4. Elliot M. Hemofiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993; 56: 1518-1527.
5. Millar A, Armstrong L, Under JVD, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 6: 1499-1502.
6. Adrian K, Mellgren K, Skogby M, Friberg L, Mellgren G, Wadenvik H. Cytokine release during long-term extracorporeal circulation in an experimental model. Artif Organs 1998; 22: 859-863.
7. Fortenberry JD, Bhardwaj V, Niemer P, Cornish JD, Wright JA, Blands L. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenator. J Pediatr 1996; 128: 670-678.
8. Moat NE, Rebuck N, Shore DF, Evans TW, Finn AH. Humoral and cellular activation in a simulated extracorporeal circuit. Ann Thorac Surg 1993; 56: 1509-1514.
9. Hammerschmidt D, Stronec D, Stroneck B, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370-377.
10. Mellgren K, Skogby M, Jarnås Å, Friberg LG, Wadenvik H, Mellgren G. Platelet activation and degradation in an experimental extracorporeal system. A comparison between a silicon membrane and a hollow-fibre oxygenator. Perfusion 1996; 11: 383-388.
11. Steinberg J, Kapelanski D, Olson J, Weiler J. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 106: 1008-16.
12. Plötz FB, Overen WV, Bartlett RH, Wildevuur CRH. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993; 105: 823-832.
13. Harker LA, Malpass TW, Branson HE, II EAH, Slichter SJ. Mechanism of abnormal bleeding in patient undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha granula release. Blood 1980; 56: 824-833.
14. Mellgren K, Friberg LG, Hedner T, Mellgren G, Wadenvik H. Blood platelet activation and membrane glycoprotein changes during extracorporeal life support (ECLS). In vitro studies. Int J Artif Organs 1995; 18: 315-321.
15. Swolin B, Roberts D, Waldenström J. Quantitative determination of plasmahemoglobin using dicarboxidine. Clin Chim Acta 1982; 121: 389-391.
16. Wang M, Chiu I, Hsu C, et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg 1996; 61: 651-656.
17. Journois D, Pouard P, Greeley W, Mauriat P, Vouhé P, Safran D. Hemofiltration during cardiopulmonary bypass in pediatric surgery. Anesthesiology 1992; 81: 1181-1189.
18. Jones E, Stuart D, Walker N. Structure of tumor necrosis factor. Nature 1989; 62: 225-228.
19. Pertersen C, Nykjaer A, Christiansen B, Heickendorff L, Mogensen S. Bioactive recombinant tumor necrosis factor-alpha: an unstable dimer? Eur J Immunol 1989; 19: 1887-1890.
20. Barrera P, Janssen E, Demacker P, Wetzels J, Meer JVD. Removal of interleukine 1-β and tumor necrosis factor from plasma by in vitro dialysis with polyacrylonitrile membranes. Lymphokine and cytokine research 1992; 2: 99-104.
21. Bouman C, Olden RV, Stoutenbeek C. Cytokine filtration and adsorption during pre- and postdilation hemofiltration in four different membranes. Blood Purific 1998; 16: 261-268.
22. Finn A, Naik S, Levinsky R, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-241.